Table 4 Main characteristics of patients with rheumatoid arthritis included in this study according to the presence or absence of metabolic syndrome
From: Metabolic syndrome in rheumatoid arthritis: case control study
Characteristics | Total (n=120) | Mets absent (n=83) | Mets present (n=37) | P value |
|---|---|---|---|---|
Mean Age (years)1 | 49± 12 | 47±12 | 52±10 | 0.03 |
Female Sex n (%)2 | 110 (91.7 ) | 74(89.2) | 36(97.3) | 0.13 |
Menopause n(%)2 | 63(51.1) | 38(45.8) | 25(67.6) | 0.02 |
RF positive n (%)2 | 93(76) | 65(78.3) | 28(75.7) | 0.74 |
ACPA positive n (%)2 | 104(85) | 73(88) | 31(83) | 0.53 |
Disease duration (yrs)1 | 7.8 ± 5.3 | 7.5±5.4 | 8.5± 4.9 | 0.31 |
CRP (mg/L)1 | 17(1à 112) | 17±21 | 19±19 | 0.59 |
ESR (mm 1erhour)1 | 33± 23 | 24± 23 | 37± 24 | 0.04 |
DAS281 | 5 ± 1.4 | 4.9±1.3 | 5.2± 1.5 | 0.32 |
Global pain (VAS : 0-100 mm)1 | 54 ± 21 | 57±17 | 53±20 | 0.36 |
HAQ1 | 1.4± 0.7 | 1.1±0.7 | 1.5±0.7 | 0.04 |
Methotrexate n (%)2 | 117(96) | 80(96) | 37(100) | 0.24 |
glucocorticoids mean daily dose (mg/j)1 | 7.3±3.05 | 7.5±2.3 | 8±2.4 | 0.44 |